高级检索
当前位置: 首页 > 详情页

Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Beijing Inst Technol, Sch Life Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China [2]Capital Med Univ, Beijing Friendship Hosp, Int Med Ctr, Beijing 100050, Peoples R China [3]Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Med Engn,Dept Biophys, Xian 710061, Peoples R China
出处:
ISSN:

关键词: Free radical generation Free radical depletion Nanotherapeutics ROS RNS scavengers Inflammatory diseases

摘要:
Free radicals, usually containing one or more unpaired electrons, are extremely unstable and highly reac-tive with other biological molecules. Recently, there has been increasing interest and substantial progress in exploring the double-edged roles of free radicals in biological systems. Particularly, nanotherapeutics based on free radical regulation have emerged as a new treatment modality against various diseases. Herein we provide a state-of-the-art review on free radicals as a double-edged sword in various disease treatments, which derives new opportunities for future nanotherapeutics. In this review, the major sources, types, and physiological functions of free radicals are firstly introduced. A specific focus is placed on the emergence of free radical generation-based nanotherapeutic approaches, including photodynamic therapy (PDT), sonodynamic therapy (SDT), radiation therapy (RT), chemodynamic therapy (CDT), ferrop-tosis therapy, and other nanotherapeutics involving free radical generation strategies. Subsequently, free radical depletion-based nanotherapeutics for alleviating molecular damage and related diseases are pre-sented with emphasis on the treatment of inflammatory diseases, neurodegenerative disorders, cardio-vascular and cerebrovascular diseases, acute kidney/liver injury, diabetes and diabetic complications, tumorigenesis and so on. Finally, some ongoing challenges and insightful perspectives of the currently developed nanotherapeutics based on regulating free radicals in biomedicine are discussed. We believe that this review would appeal to the researchers from interdisciplinarity fields of nanoscience, chemistry, biology, material science, pharmaceutical science, as well as clinical medicine to push the development of related nanotherapeutic technologies.(c) 2022 Elsevier B.V. All rights reserved.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2022]版
大类 | 1 区 化学
小类 | 1 区 无机化学与核化学
最新[2025]版
大类 | 1 区 化学
小类 | 1 区 无机化学与核化学
JCR分区:
出版当年[2021]版:
Q1 CHEMISTRY, INORGANIC & NUCLEAR
最新[2023]版:
Q1 CHEMISTRY, INORGANIC & NUCLEAR

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2021版] 出版当年五年平均[2017-2021] 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者单位: [1]Beijing Inst Technol, Sch Life Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)